Press release
Glucagon-like Peptide 1 (GLP-1) Analogues Market Growth, Trends & Forecast | Industry Insights 2024-2031 | Sanofi, AstraZeneca, Boehringer Ingelheim, Inc.
Glucagon-like Peptide 1 (GLP-1) Analogues Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/glucagon-like-peptide-1-analogues-market?sz
What is the projected growth of the Global Glucagon-like Peptide 1 (GLP-1) Analogues market?
The Global Glucagon-like Peptide 1 (GLP-1) Analogues Market reached US$51.2 billion in 2023 and is expected to reach US$190.48 billion by 2031, growing at a CAGR of 17.9 % during the forecast period 2024-2031.
What is Glucagon-like Peptide 1 (GLP-1) Analogues Market?
The Glucagon-like Peptide 1 (GLP-1) Analogues market focuses on medications that regulate blood sugar levels and support weight management, primarily for diabetes and obesity treatment. Driven by rising diabetes prevalence, obesity concerns, and advancements in drug formulations, the market is expanding. However, high treatment costs, regulatory hurdles, and potential side effects pose challenges.
Who are the major players in the Glucagon-like Peptide 1 (GLP-1) Analogues market?
The prominent players in Glucagon-like Peptide 1 (GLP-1) Analogues market research report are:
Eli Lilly and Company, Novo Nordisk A/S., Sanofi, AstraZeneca, Boehringer Ingelheim, Inc., Glenmark Pharmaceuticals Ltd., Hanmi Pharm.Co., Ltd., Amgen Inc., Gmax Biopharm., and Sciwind Biosciences Co., Ltd. among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In August 2024, Metsera, a newly launched clinical-stage biopharmaceutical company, secured $290 million in funding to advance innovative treatments for obesity and metabolic diseases, with a strong focus on GLP-1 receptor agonists.
In June 2024, Teva Pharmaceuticals introduced the first generic version of a GLP-1 receptor agonist in the U.S., specifically liraglutide 1.8 mg. This milestone in diabetes treatment offers a more affordable option for patients managing type 2 diabetes.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/glucagon-like-peptide-1-analogues-market
Market Segments
By Product: Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda, Victoza, Zepbound, Others.
By Type: Long-acting GLP-1 Agonist, Short-acting GLP-1 Agonist.
By Route of Administration: Subcutaneous, Oral.
By Application: Type 2 Diabetes Mellitus, Obesity, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
The Glucagon-like Peptide 1 (GLP-1) Analogues industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Glucagon-like Peptide 1 (GLP-1) Analogues Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/glucagon-like-peptide-1-analogues-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glucagon-like Peptide 1 (GLP-1) Analogues Market Growth, Trends & Forecast | Industry Insights 2024-2031 | Sanofi, AstraZeneca, Boehringer Ingelheim, Inc. here
News-ID: 3895420 • Views: …
More Releases from DataM Intelligence 4Market Research
Green Steel Market is expected to reach US$ 140,435.7 million by 2031 | Major Co …
Market Size and Growth:
The Global Green Steel Market size reached US$ 201.3 million in 2022 and is expected to reach US$ 140,435.7 million by 2031, growing with a CAGR of 126.7% during the forecast period 2024-2031. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/green-steel-market?sz
The Green Steel Market refers to the global industry involved in the production, distribution, and adoption of environmentally sustainable steel. It focuses on reducing…
Bauxite Market is expected to reach US$ 19.7 billion by 2030 | Top Companies - R …
Market Size and Growth:
The Global Bauxite Market Size reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2030, growing with a CAGR of 3.7% during the forecast period 2024-2031. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/bauxite-market?sz
The Bauxite Market refers to the global trade and production of bauxite, the primary ore for aluminum. It encompasses mining, processing, and distribution activities,…
Construction Aluminum Market is expected to reach US$1,20,653.41 million by 2032 …
Market Size and Growth:
The Global Construction Aluminum Market Size reached US$75,345.01 million in 2024 and is expected to reach US$1,20,653.41 million by 2032, growing at a CAGR of 6.17% during the forecast period 2025-2032. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/construction-aluminum-market?sz
The Construction Aluminum Market refers to the global industry involved in the production, distribution, and use of aluminum materials for construction purposes. It includes aluminum products…
Integrated Workplace Management Market 2025-2032 | Latest Developments & Growth …
Market Overview:
The Global Integrated Workplace Management Market is estimated to reach at a CAGR of 12.5% within the forecast period (2024-2031). According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/integrated-workplace-management-market?sz
The Integrated Workplace Management System (IWMS) Market encompasses software solutions that help organizations efficiently manage real estate, facilities, and workplace resources. It integrates space planning, asset management, maintenance, energy optimization, and workplace analytics, enhancing operational efficiency, cost savings, and…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
